- Home
- AADI vs ELVA Comparison
AADI vs ELVA Comparison
Compare AADI & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- ELVA
- Stock Information
- Founded
- AADI 2011
- ELVA 1996
- Country
- AADI United States
- ELVA Canada
- Employees
- AADI N/A
- ELVA N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- ELVA
- Sector
- AADI Health Care
- ELVA
- Exchange
- AADI Nasdaq
- ELVA Nasdaq
- Market Cap
- AADI 59.4M
- ELVA 71.0M
- IPO Year
- AADI N/A
- ELVA N/A
- Fundamental
- Price
- AADI $2.34
- ELVA $2.23
- Analyst Decision
- AADI Hold
- ELVA Strong Buy
- Analyst Count
- AADI 3
- ELVA 4
- Target Price
- AADI $1.75
- ELVA $8.75
- AVG Volume (30 Days)
- AADI 109.6K
- ELVA 133.0K
- Earning Date
- AADI 11-06-2024
- ELVA 12-12-2024
- Dividend Yield
- AADI N/A
- ELVA N/A
- EPS Growth
- AADI N/A
- ELVA N/A
- EPS
- AADI N/A
- ELVA N/A
- Revenue
- AADI $25,070,000.00
- ELVA $44,615,000.00
- Revenue This Year
- AADI $9.39
- ELVA $82.20
- Revenue Next Year
- AADI $6.15
- ELVA $52.69
- P/E Ratio
- AADI N/A
- ELVA N/A
- Revenue Growth
- AADI 7.80
- ELVA 1.26
- 52 Week Low
- AADI $1.21
- ELVA $1.67
- 52 Week High
- AADI $2.63
- ELVA $4.58
- Technical
- Relative Strength Index (RSI)
- AADI 58.75
- ELVA 40.92
- Support Level
- AADI $2.25
- ELVA $2.15
- Resistance Level
- AADI $2.45
- ELVA $2.90
- Average True Range (ATR)
- AADI 0.11
- ELVA 0.20
- MACD
- AADI -0.01
- ELVA -0.07
- Stochastic Oscillator
- AADI 39.89
- ELVA 7.83
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and industry leading battery longevity. Geographically it earns key revenue from the United States.